Loading
CM
Conavi Medical Corp. Stock: price and insider trades · Canada
Conavi Medical Corp.: what insiders have been doing
Conavi Medical Corp. belongs to the Health Care sector. Filings by its managers are published through SEDI. Between 24 October 2025 and 24 October 2026, 7 insiders published 10 filings.
No insider sold shares on the market over the period. Instead, the filings list 3 purchases, made by 1 insider. No amount is published for 3 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 senior executive.
The last purchase on record was published on 23 October 2026, which is 0 days ago. Typically, a trade is published a median of 4 days after it takes place. Until a filing is published, the market cannot know about the trade.
Across the 2,734 companies tracked on its exchange, the median is 14 filings; at 10 filings, this issuer sits below that mark. Looking back to 2024, when coverage begins, insiders filed 5 purchases and no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
26
Thresholds
n/a
Buy Volume
€477,180
5 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleThomas Lawrence Looby3 buys
CPOINT Capital Corp.2 buys
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended September 2025 · cache
CA$0.11
Analyst consensus
1 analystsCA$1.30Target CA$1.30(+1138%)CA$1.30
Income statement
RevenueCA$9.1M
Gross profitCA$7.6M84% margin
EBITDA-CA$8M-88% margin
Net income-CA$20.5M-224.9% margin
Valuation
Beta-0.36
Balance sheet & cash
Market capCA$14.5M
Total debtCA$19.9M
Free Cash Flow-CA$25.3M
Profitability & ownership
ROA-99.9%
% insiders32.6%
% institutions0.0%
Last declaration on 23 October 2026
Declarations26 total
12,400 sharesCommon SharesTSXSEDI:4794082
Canonical exit: 21 Jan 2027 (T+90)
7,800 sharesCommon SharesTSXSEDI:4794081
Canonical exit: 20 Jan 2027 (T+90)
26,000 sharesCommon SharesTSXSEDI:4794079
Canonical exit: 17 Jan 2027 (T+90)
300,000 sharesOptionsTSXSEDI:4794046
400,000 sharesOptionsTSXSEDI:4794043
400,000 sharesOptionsTSXSEDI:4794041
500,000 sharesOptionsTSXSEDI:4794038
21,750,180 sharesCommon SharesTSXSEDI:4629031
Common SharesTSXSEDI:4629025
21,750,180 sharesCommon SharesTSXSEDI:4629026
1,250,000 shares@ CA$0.4066.7% of flowCommon SharesTSXSEDI:4502922
Canonical exit: 22 Jul 2025 (T+90)
625,000 shares@ CA$0.4033.3% of flowCommon SharesTSXSEDI:4502921
Canonical exit: 22 Jul 2025 (T+90)
Common SharesTSXSEDI:4391094
Common SharesTSXSEDI:4391096
Common SharesTSXSEDI:4390930
Common SharesTSXSEDI:4390927
Common SharesTSXSEDI:4390954
11,520 sharesCommon SharesTSXSEDI:4390950
Common SharesTSXSEDI:4390934
Common SharesTSXSEDI:4390958
7,993 sharesCommon SharesTSXSEDI:4390953
6,284 sharesCommon SharesTSXSEDI:4390949
Common SharesTSXSEDI:4390957
Common SharesTSXSEDI:4390947
Common SharesTSXSEDI:4390944
25 of 26 declarations
About Conavi Medical Corp.
Conavi Medical Corp. is a company focused on developing innovative medical technologies for the diagnosis and treatment of cardiovascular diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
